195 related articles for article (PubMed ID: 21240526)
1. Evaluation of the association studies of single nucleotide polymorphisms and hepatocellular carcinoma: a systematic review.
Jin F; Xiong WJ; Jing JC; Feng Z; Qu LS; Shen XZ
J Cancer Res Clin Oncol; 2011 Jul; 137(7):1095-104. PubMed ID: 21240526
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive evaluation of single nucleotide polymorphisms associated with hepatocellular carcinoma risk in Asian populations: A systematic review and network meta-analysis.
Zhang C; Ye Z; Zhang Z; Zheng J; Tang Y; Hou E; Huang Z; Meng L
Gene; 2020 Apr; 735():144365. PubMed ID: 31935498
[TBL] [Abstract][Full Text] [Related]
3. Associations between lncRNA-related polymorphisms and hepatocellular carcinoma risk: A two-stage case-control study.
Li Y; He HC; Zhou DL; Liu Q; Zhang X; Yang XH; Ye ZL; Peng JL; Tang T; Su X; He CY
J Gastroenterol Hepatol; 2021 Jan; 36(1):233-239. PubMed ID: 32453900
[TBL] [Abstract][Full Text] [Related]
4. The association of six polymorphisms of five genes involved in three steps of nucleotide excision repair pathways with hepatocellular cancer risk.
Wang B; Xu Q; Yang HW; Sun LP; Yuan Y
Oncotarget; 2016 Apr; 7(15):20357-67. PubMed ID: 26967386
[TBL] [Abstract][Full Text] [Related]
5. Knowledge-based analyses reveal new candidate genes associated with risk of hepatitis B virus related hepatocellular carcinoma.
Jiang D; Deng J; Dong C; Ma X; Xiao Q; Zhou B; Yang C; Wei L; Conran C; Zheng SL; Ng IO; Yu L; Xu J; Sham PC; Qi X; Hou J; Ji Y; Cao G; Li M
BMC Cancer; 2020 May; 20(1):403. PubMed ID: 32393195
[TBL] [Abstract][Full Text] [Related]
6. Gene variations related to the hepatocellular carcinoma: Results from a field synopsis and Bayesian revaluation.
Penha Mesquita A; Victor Oliveira Monteiro A; Luiz Araújo Bentes Leal A; Dos Santos Pessoa L; de Siqueira Amorim Júnior J; Rogério Souza Monteiro J; Andrade de Sousa A; Fernando Pereira Vasconcelos D; Carolina Alves de Oliveira A; Leão Pereira A; Rodolfo Pereira da Silva F
Gene; 2023 Jun; 869():147392. PubMed ID: 36966980
[TBL] [Abstract][Full Text] [Related]
7. Impact of TP53 codon 72 and MDM2 promoter 309 allelic dosage in a Moroccan population with hepatocellular carcinoma.
Ezzikouri S; Essaid El Feydi A; Afifi R; Benazzouz M; Hassar M; Pineau P; Benjelloun S
Int J Biol Markers; 2011; 26(4):229-33. PubMed ID: 22180176
[TBL] [Abstract][Full Text] [Related]
8. Systematic analyses and comprehensive field synopsis of genetic association studies in hepatocellular carcinoma.
Dong D; Zou Y; Zhang P; Wu Z
Oncotarget; 2016 Jul; 7(29):45757-45763. PubMed ID: 27304192
[TBL] [Abstract][Full Text] [Related]
9. Association Between Polymorphisms of Interleukin 1 Family Genes and Hepatocellular Carcinoma.
Tak KH; Yu GI; Lee MY; Shin DH
Med Sci Monit; 2018 May; 24():3488-3495. PubMed ID: 29802240
[TBL] [Abstract][Full Text] [Related]
10. Three common functional polymorphisms in microRNA encoding genes in the susceptibility to hepatocellular carcinoma: a systematic review and meta-analysis.
Xu Y; Li L; Xiang X; Wang H; Cai W; Xie J; Han Y; Bao S; Xie Q
Gene; 2013 Sep; 527(2):584-93. PubMed ID: 23791656
[TBL] [Abstract][Full Text] [Related]
11. Thymidylate synthase gene polymorphisms as important contributors affecting hepatocellular carcinoma prognosis.
Wang X; Sun X; Du X; Zhou F; Yang F; Xing J; Dong G; Guo X
Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):319-326. PubMed ID: 28043790
[TBL] [Abstract][Full Text] [Related]
12. MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population.
Akkiz H; Sümbül AT; Bayram S; Bekar A; Akgöllü E
Cancer Epidemiol; 2010 Aug; 34(4):448-52. PubMed ID: 20447891
[TBL] [Abstract][Full Text] [Related]
13. Donor one‑carbon metabolism gene single nucleotide polymorphisms predict the susceptibility of cancer recurrence after liver transplantation.
Wang C; Lu D; Ling Q; Chen J; Liu Z; Guo H; Xu X; Zheng S
Gene; 2019 Mar; 689():97-101. PubMed ID: 30529095
[TBL] [Abstract][Full Text] [Related]
14. The expression of long non coding RNA genes is associated with expression with polymorphisms of HULC rs7763881 and MALAT1 rs619586 in hepatocellular carcinoma and HBV Egyptian patients.
Motawi TMK; El-Maraghy SA; Sabry D; Mehana NA
J Cell Biochem; 2019 Sep; 120(9):14645-14656. PubMed ID: 31009106
[TBL] [Abstract][Full Text] [Related]
15. Genetic Variations in XRCC4 (rs1805377) and ATF6 (rs2070150) are not Associated with Hepatocellular Carcinoma in Thai Patients with Hepatitis B Virus Infection.
Makkoch J; Praianantathavorn K; Sopipong W; Chuaypen N; Tangkijvanich P; Payungporn S
Asian Pac J Cancer Prev; 2016; 17(2):591-5. PubMed ID: 26925648
[TBL] [Abstract][Full Text] [Related]
16. Interaction between p53 codon 72 and MDM2 309T>G polymorphisms and the risk of hepatocellular carcinoma.
Qiu M; Liu Y; Yu X; Qin L; Bei C; Zeng X; Qiu X; Tang B; He S; Yu H
Tumour Biol; 2016 Mar; 37(3):3863-70. PubMed ID: 26476535
[TBL] [Abstract][Full Text] [Related]
17. [Association between microRNA single nucleotide polymorphisms and the risk of hepatocellular carcinoma].
Li W; Ma Y; Zeng D; Zhang J; Wang R; Hu J; Yang D; Hu H; Wang J; Liu J
Rev Med Chil; 2016 Apr; 144(4):508-15. PubMed ID: 27401384
[TBL] [Abstract][Full Text] [Related]
18. Association of PINX1 but not TEP1 Polymorphisms with Progression to Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B Virus Infection.
Sriprapun M; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Payungporn S; Tangkijvanich P
Asian Pac J Cancer Prev; 2016; 17(4):2019-25. PubMed ID: 27221889
[TBL] [Abstract][Full Text] [Related]
19. miR-492G>C polymorphism (rs2289030) is associated with overall survival of hepatocellular carcinoma patients.
Yu G; Xiao Q; Ma XP; Chen X; Shi Z; Zhang LY; Chen H; Zhang P; Ding DL; Huang HX; Saiyin H; Chen TY; Lu PX; Wang NJ; Yu H; Sun J; Conran C; Zheng SL; Xu J; Yu L; Jiang DK
Tumour Biol; 2016 Jul; 37(7):8961-72. PubMed ID: 26753964
[TBL] [Abstract][Full Text] [Related]
20. Association between five types of Tumor Necrosis Factor-α gene polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Wungu CDK; Ariyanto FC; Prabowo GI; Soetjipto ; Handajani R
BMC Cancer; 2020 Nov; 20(1):1134. PubMed ID: 33228594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
